DBT for Borderline Personality Disorder
(FASTER-DBT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a shorter, 6-month dialectical behavior therapy (DBT) program is as effective as the standard 12-month program for individuals with borderline personality disorder (BPD). The researchers aim to determine if the shorter treatment can reduce self-harm and suicidal behaviors while being more accessible and cost-effective. Participants must have a history of self-harm, reside in the Greater Toronto or Greater Vancouver areas, and not have recently undergone extensive DBT. This study could increase DBT availability for those in need. As an unphased trial, it offers a unique opportunity to contribute to research that could make effective therapy more accessible and affordable.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this DBT protocol is safe for treating borderline personality disorder?
Research has shown that Dialectical Behaviour Therapy (DBT) is generally safe for people with Borderline Personality Disorder (BPD). Studies have found that DBT can reduce self-harm and improve mental health. Reviews of DBT treatments indicate that people with BPD and their loved ones often have positive experiences with this therapy.
Specific studies examined the safety of DBT, including online versions, and found it well-tolerated. These studies reported significant improvements in symptoms and quality of life without major side effects. This suggests that DBT, whether in-person or online, is a safe option for managing BPD symptoms.
In summary, research supports the safety of both 6-month and 12-month DBT programs, providing reassurance to those considering this therapy.12345Why are researchers excited about this trial?
Researchers are excited about Dialectical Behaviour Therapy (DBT) for Borderline Personality Disorder because it offers a structured, time-limited approach that could make therapy more accessible and manageable for patients. Unlike many current treatments that often require long-term commitment, this trial compares a 6-month and a 12-month DBT program, providing insights into the optimal duration for effective results. DBT is unique in its combination of cognitive-behavioral techniques and mindfulness practices, which can help individuals develop emotional regulation and interpersonal skills more effectively than traditional therapies. This trial aims to determine whether a shorter, 6-month DBT program can deliver comparable benefits to the standard 12-month duration, potentially allowing more individuals to access and complete this impactful treatment.
What evidence suggests that this trial's treatments could be effective for borderline personality disorder?
This trial will compare two durations of Dialectical Behavior Therapy (DBT) for treating borderline personality disorder (BPD): a 6-month program and a 12-month program. Studies have shown that DBT effectively treats BPD. Research indicates that both 6-month and 12-month DBT programs help reduce self-harm and impulsive behavior in people with BPD. One study found that 6 months of DBT is nearly as effective as 12 months in improving symptoms. However, the 12-month program may offer more lasting improvements in mood stability and reduce the need for hospitalization. Overall, DBT is a proven therapy for effectively managing BPD symptoms.678910
Who Is on the Research Team?
Shelley McMain, Ph.D
Principal Investigator
The Centre for Addiction and Mental Health
Are You a Good Fit for This Trial?
This trial is for individuals with Borderline Personality Disorder who have self-harmed at least twice in the last five years, once within the past eight weeks. Participants must speak English, consent to join, not have had extensive DBT therapy recently, and live in specific areas of Canada with local health insurance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 6 months or 12 months of standard dialectical behaviour therapy (DBT) treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments conducted at 3-month intervals
Long-term Follow-up
Participants continue to be monitored for an additional year to assess long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Dialectical Behaviour Therapy-12 months
- Dialectical Behaviour Therapy-6 months
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
Simon Fraser University
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator